EUVIMEDEUVIMED entdecken
Crossref

Complement decay-accelerating factor inhibits inflammation-induced myopia development

Yung-Lan Chou, Yu-An Hsu, Chi-Fong Lin, Chih-Sheng Chen, Peng-Tai Tien, Yao-Chien Wang, Ching-Yao Chang, En-Shyh Lin, Jamie Jiin-Yi Chen, Ming-Yen Wu, Chun-Yu Chuang, Hui-Ju Lin und 1 weitere

Molecular Immunology · 2024

DOI: 10.1016/j.molimm.2024.05.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Immunology, 2024. Verfasst von Yung-Lan Chou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan; School of Chinese Medicine, China Me…. Hauptthemen laut MEDLINE: CD55 Antigens, Disease Models, Animal, Inflammation, Myopia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myopia is regarded as a worldwide epidemic ocular disease, has been proved related to inflammation. CD55, also known as decay-accelerating factor (DAF) can modulate the activation of complement through inhibiting the formation of complement 3 convertase and its dysregulation is involved in various inflammatory diseases. To investigate the association between CD55 and myopia, and to test whether CD55 can inhibit myopia development by suppressing inflammation in the eye, we use three different animal models including monocular form-deprivation myopia, myopia induced by TNF-α administration and allergic conjunctivitis animal model to reveal the CD55 in myopia development. The tears of thirty-eight participants with different spherical equivalents were collected and CD55 in the tears were also analyzed. Complement 3 and complement 5 levels increased while CD55 levels decreased in allergic conjunctivitis and myopic eyes. After anti-inflammatory drugs administration, CD55 expression was increased in monocular form-deprivation myopia model. We also found inflammatory cytokines TGF-β, IL-6, TNF-α, and IL-1β may enhance complement 3 and complement 5 activation while CD55 level was suppressed contrary. Moreover, lower CD55 levels were found in the tears of patients with myopia with decreased diopter values. Finally, CD55-Fc administration on the eyelids can inhibit the elongation of axial length and change of refractive error. CD55-Fc application also suppress myopia development subsequent to complement 3 and complement 5 reduction and can lower myopia-specific (MMP-2 and TGF-β) cytokine expression in TNF-α induced myopia animal model. This suggests that CD55 can inhibit myopia development by suppression of complement activation and eventual down-regulation of inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD55 AntigensDisease Models, AnimalInflammationMyopiaAdolescentAnimalsFemaleHumansMaleYoung AdultComplement ActivationComplement C3Conjunctivitis, AllergicCytokinesTearsTumor Necrosis Factor-alphaComplement C5

Stichwörter der Autor:innen

CD55Complementary systemInflammationMyopiaRetinadecay-accelerating factor (DAF)

Substanzen

CD55 AntigensComplement C3CytokinesTumor Necrosis Factor-alphaC3 protein, humanComplement C5

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan; School of Chinese Medicine, China Medical University, Taichung, Taiwan.
  • School of Chinese Medicine, China Medical University, Taichung, Taiwan; Department of Chemistry, National Central University, Taoyuan, Taiwan.
  • Ph.D. Program for Health Science and industry, China Medical University, Taichung, Taiwan.
  • Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan; Division of Chinese Medicine, Asia University Hospital, Taichung, Taiwan.
  • School of Medicine, China Medical University, Taichung, Taiwan; Eye center, China Medical University Hospital, Taichung, Taiwan.
  • Department of Emergency Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan.

Zitieren

APA

Chou, Y. L., Hsu, Y. A., Lin, C. F., Chen, C. S., Tien, P. T., Wang, Y. C., Chang, C. Y., Lin, E. S., Chen, J. J., Wu, M. Y., Chuang, C. Y., Lin, H. J., & Wan, L. (2024). Complement decay-accelerating factor inhibits inflammation-induced myopia development. Molecular Immunology. https://doi.org/10.1016/j.molimm.2024.05.005

Vancouver

Chou YL, Hsu YA, Lin CF, Chen CS, Tien PT, Wang YC, et al. Complement decay-accelerating factor inhibits inflammation-induced myopia development. Molecular Immunology. 2024. doi:10.1016/j.molimm.2024.05.005

BibTeX
@article{Chou2024,
  author = {Chou, Yung-Lan and Hsu, Yu-An and Lin, Chi-Fong and Chen, Chih-Sheng and Tien, Peng-Tai and Wang, Yao-Chien and Chang, Ching-Yao and Lin, En-Shyh and Chen, Jamie Jiin-Yi and Wu, Ming-Yen and Chuang, Chun-Yu and Lin, Hui-Ju and Wan, Lei},
  title = {Complement decay-accelerating factor inhibits inflammation-induced myopia development},
  journal = {Molecular Immunology},
  year = {2024},
  doi = {10.1016/j.molimm.2024.05.005}
}
Kostenlos starten →